READOUT // 09 — CONTACT
Contact MOTS-c Chemical
Editorial correspondence about the MOTS-c research record — corrections, citation questions, and source suggestions.
Editorial Correspondence
MOTS-c Chemical is an editorial publication, and this channel is for editorial matters only: corrections to a summary, questions about a citation, or a peer-reviewed study you think we should log. We read every message about the accuracy of the research readout.
What this channel is not: it is not a route to medical advice, a clinical consultation, a prescription, or a purchase. We are not a clinic and we do not employ clinicians; we cannot advise on whether MOTS-c is appropriate for any individual, and we cannot supply, source, or price the compound. Questions of that kind are outside what this site does and are better directed to an appropriately licensed professional.
Use the Form
Send editorial correspondence using the form below. Please include the page and, where relevant, the reference number so we can check the source quickly. We prioritize messages that flag a factual error or point to a study missing from the MOTS-c references and citations page. Because every quantitative claim on this site is tied to a numbered source, a precise pointer — the page, the section, and the reference — lets us verify and correct far faster than a general note.
For questions about the regulatory readout, the MOTS-c legal status and FDA 503A category page cites its FDA sources directly; please reference the specific source you are asking about. We do not provide legal advice, and we treat the regulatory page as general information about the landscape. We also welcome newly published peer-reviewed studies on MOTS-c that extend or revise the record — the literature on this peptide is active, and we update the readout as it grows. What we cannot answer are individual medical or purchasing questions, which fall outside an editorial publication's remit.